Loading...
Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets
BACKGROUND: Triple negative breast cancer (TNBC) is high-risk due to its rapid drug resistance and recurrence, metastasis, and lack of targeted therapy. So far, no molecularly targeted therapeutic agents have been clinically approved for TNBC. It is imperative that we discover new targets for TNBC t...
Na minha lista:
| Udgivet i: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5265847/ https://ncbi.nlm.nih.gov/pubmed/27472710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004321 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|